UCB Selects Rowen for $2B Biopharmaceutical Manufacturing Campus
Go back to UCB Selects Rowen for $2B Biopharmaceutical Manufacturing Campus| (NYSE: UCB) | Delayed: 33.22 +0.97 (3.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.25 | 52 Week High | $ | |||
| Open | $32.78 | 52 Week Low | $ | |||
| Day High | $33.28 | P/E | N/A | |||
| Day Low | $32.77 | EPS | $ | |||
| Volume | 773,129 | |||||
